Friday 20 October
Rethinking Cancer Therapies: Fresh Perspectives on MDM2-p53, HER2, DLL3 and Other Targets in Cancer
Friday, 18:00 - 19:30
View the satellite invitation
Saturday 21 October
Keeping the Outcome in Mind: Applying Best Practices for Managing HR+/HER2- EBC at High Risk of Recurrence
Saturday, 13:00 - 14:30
View the satellite invitation
Oncologists at the Helm of Translating Biomarker Insights into Actionable Patient Care
Saturday, 18:30 - 19:50
View the satellite invitation
Monday 23 October
Shifting the Paradigm in Cancer Screening: Multi-Cancer Early Detection (MCED) Testing
Monday, 13:00 - 14:30
View the satellite invitation